Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia.
about
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisPolycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FElevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome.Novel and emerging therapies for the treatment of polycythemia veraWHO classification of myeloproliferative neoplasms (MPN): A critical update.Rethinking the diagnostic criteria of polycythemia vera.Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options.European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials.JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis.Masked polycythemia vera (mPV): results of an international study.The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria.Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.Application of the optimized CO-rebreathing method for determination of hemoglobin mass in patients with polycythemia vera.The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.Masked polycythemia vera diagnosed according to WHO and BCSH classification.
P2860
Q26772881-155265F7-5248-4CF3-92B4-27F16ABBAB8DQ26795666-17375509-80E9-44F7-B256-93A64DE89A78Q34635408-79EF8D68-C37E-4920-9A9C-236AB38D6085Q37069633-D5CC0527-D491-4702-9261-236D9A3CA468Q38154519-A750A610-280A-4003-8163-A455BDB332E1Q38172388-3E475590-07E5-4E03-AF64-984E5F61F146Q38255717-EFD60E31-B90A-424D-A05C-71B6064A0D52Q38689790-E07860CD-5F71-45C4-A400-620964020406Q39979643-BB468E0E-02E0-42E2-AB2F-E4C83328B752Q45797468-E80D9C83-EE3E-4CB5-843E-F547A0193B32Q46636672-36C9F8B9-76FB-4EDD-A298-B5176098290EQ46731979-64038EA5-EDAA-4693-99A8-F9D0ABA9D01AQ48321438-A3A05984-32E4-4755-B8D1-288A2EE93548Q50449411-5E6CAF91-0D77-47BF-A94C-008878C40BBEQ50479849-1DF1FB4F-B22C-459E-8652-C6226AD68A38Q54336750-79AFB823-6DEE-4D29-A290-33937208A9A0Q54400423-4E87D956-AF83-4262-80C3-14C38A264B80
P2860
Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Red cell mass measurement in p ...... or essential thrombocythemia.
@ast
Red cell mass measurement in p ...... or essential thrombocythemia.
@en
type
label
Red cell mass measurement in p ...... or essential thrombocythemia.
@ast
Red cell mass measurement in p ...... or essential thrombocythemia.
@en
prefLabel
Red cell mass measurement in p ...... or essential thrombocythemia.
@ast
Red cell mass measurement in p ...... or essential thrombocythemia.
@en
P2093
P2860
P1433
P1476
Red cell mass measurement in p ...... or essential thrombocythemia.
@en
P2093
Agueda Ancochea
Alberto Alvarez-Larrán
Anna Angona
Beatriz Bellosillo
Carlos Besses
Carme Pedro
Francesc García-Pallarols
Luz Martínez-Avilés
P2860
P304
P356
10.3324/HAEMATOL.2012.067348
P577
2012-06-11T00:00:00Z